Skip to content

Evaluation of Telerehabilitation Following Inpatient or Outpatient Rehabilitation Phase II

Evaluation Der Telerehabilitation im Anschluss an Eine stationäre Oder Ambulante Rehabilitation Phase II - Pilotprojekt [Evaluation of Telerehabilitation Following Inpatient or Outpatient Rehabilitation Phase II - Pilot Project]

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05493306
Enrollment
126
Registered
2022-08-09
Start date
2021-04-08
Completion date
2022-06-30
Last updated
2022-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal Diseases, Oncology

Keywords

Telerehabilitation, Evaluation, Usability

Brief summary

Telerehabilitation is implemented in the Pensionsversicherungsanstalt (PVA) as an independent rehabilitation offer following a rehabilitation phase II. This offer primarily includes physiotherapeutic training units in group settings and in individual counselling, as well as health-related educational sessions and doctor's consultations via video conferencing, initially for rehabilitation patients with diseases of the musculoskeletal system or oncological diseases. The first stage of the implementation process was evaluated with a focus on acceptance, usability and feasibility from the perspective of patients and treatment team. The evaluation was based on a convergent mixed methods design (Creswell & Plano Clark, 2017) to draw on the strengths of qualitative and quantitative research approaches (Creswell & Creswell, 2018). Qualitative and quantitative data were generated in parallel and treated equally. The perspective of the patients (N = 86) was collected through online questionnaires and in-depth telephone interviews (N = 22) and that of the treatment team through a questionnaire survey (N = 32) and focus group interviews (N = 24). The administrative team (N = 8) was asked for their assessment in a focus group interview. Technical difficulties in the implementation of telerehabilitation were documented by the treatment team. The consolidation of these multi-perspective results took place at the level of interpretation.

Interventions

None listed

Sponsors

Pensionsversicherungsanstalt
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

Patients who have completed rehabilitation (phase II) with the indications: * musculoskeletal diseases * oncology.

Exclusion criteria

* Failure to obtain the declaration of consent * Lack of the required technical aids (mobile phone, tablet or PC) * Lack of the technical skills to operate the app and thus to participate in telerehabilitation.

Design outcomes

Primary

MeasureTime frameDescription
Usability of the telerehabilitationApril 2021 - May 2022The patients' perspective was collected with a self-developed online questionnaire (N = 86) and in-depth telephone interviews (N = 22). The questionnaires were analysed descriptively. The telephone interviews were protocolled and subsequently coded and categorised. The perspective of the treatment team was collected with a self-developed questionnaire (N = 32) and focus group interviews (N = 24). In addition, the administrative team (N = 8) was asked for their assessments in a focus group interview. The questionnaires were analysed descriptively. The focus group interview was recorded and subsequently coded and categorised.
Feasibility of the telerehabilitationApril 2021 - May 2022Technical difficulties concerning the video calls were continuously documented by the treatment team. The data were analysed descriptively.
Acceptance of the telerehabilitationApril 2021 - May 2022The patients' perspective was collected with a self-developed online questionnaire (N = 86) and in-depth telephone interviews (N = 22). The questionnaires were analysed descriptively. The telephone interviews were protocolled and subsequently coded and categorised. The perspective of the treatment team was collected with a self-developed questionnaire (N = 32) and focus group interviews (N = 24). The questionnaires were analysed descriptively. The focus group interviews were recorded and subsequently coded and categorised.

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026